MeiraGTx Holdings Stock

MeiraGTx Holdings Revenue 2024

MeiraGTx Holdings Revenue

32.78 M USD

Ticker

MGTX

ISIN

KYG596651029

WKN

A2JGHF

In 2024, MeiraGTx Holdings's sales reached 32.78 M USD, a 133.83% difference from the 14.02 M USD sales recorded in the previous year.

The MeiraGTx Holdings Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e972.51-
2028e771.53-
2027e617.82-
2026e208.61-
2025e247.57-
2024e32.78-
202314.02-
202215.92-
202137.7-
202015.56-
201913.29-
2018--
2017--
2016--

MeiraGTx Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into MeiraGTx Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by MeiraGTx Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects MeiraGTx Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of MeiraGTx Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into MeiraGTx Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing MeiraGTx Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on MeiraGTx Holdings’s growth potential.

MeiraGTx Holdings Revenue, EBIT and net profit per share

DateMeiraGTx Holdings RevenueMeiraGTx Holdings EBITMeiraGTx Holdings Net Income
2029e972.51 M undefined0 undefined418.42 M undefined
2028e771.53 M undefined321.11 M undefined281.83 M undefined
2027e617.82 M undefined219.4 M undefined192.48 M undefined
2026e208.61 M undefined13.02 M undefined11.81 M undefined
2025e247.57 M undefined119.78 M undefined67.7 M undefined
2024e32.78 M undefined-132.18 M undefined-134.93 M undefined
202314.02 M undefined-137.06 M undefined-84.03 M undefined
202215.92 M undefined-116.36 M undefined-129.62 M undefined
202137.7 M undefined-72.76 M undefined-79.56 M undefined
202015.56 M undefined-62.55 M undefined-57.99 M undefined
201913.29 M undefined-58.27 M undefined-54.75 M undefined
20180 undefined-78.1 M undefined-84.67 M undefined
20170 undefined-31.68 M undefined-31.85 M undefined
20160 undefined-19.46 M undefined-19.57 M undefined

MeiraGTx Holdings stock margins

The MeiraGTx Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of MeiraGTx Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for MeiraGTx Holdings.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the MeiraGTx Holdings's sales revenue. A higher gross margin percentage indicates that the MeiraGTx Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the MeiraGTx Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the MeiraGTx Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the MeiraGTx Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the MeiraGTx Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the MeiraGTx Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

MeiraGTx Holdings Margin History

MeiraGTx Holdings Gross marginMeiraGTx Holdings Profit marginMeiraGTx Holdings EBIT marginMeiraGTx Holdings Profit margin
2029e0 %0 %43.02 %
2028e0 %41.62 %36.53 %
2027e0 %35.51 %31.15 %
2026e0 %6.24 %5.66 %
2025e0 %48.38 %27.35 %
2024e0 %-403.28 %-411.68 %
20230 %-977.82 %-599.46 %
20220 %-730.9 %-814.2 %
20210 %-193 %-211.03 %
20200 %-401.99 %-372.69 %
20190 %-438.45 %-411.96 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %

MeiraGTx Holdings Aktienanalyse

What does MeiraGTx Holdings do?

MeiraGTx Holdings PLC is a leading company in the field of gene therapy and develops innovative therapies for various genetic diseases. The company was founded in 2015 and is headquartered in London, UK, with additional locations in the USA. MeiraGTx aims to change lives by developing gene therapy-based drugs that enable a cure or permanent relief from serious illnesses. History: MeiraGTx was founded by renowned genome researcher Dr. Gregory A. Petsko and an experienced team of scientists and experts in the biotechnology and pharmaceutical fields. With an experienced team and significant investment capital, MeiraGTx has established itself as a leading company in the field of gene therapy. Business model: MeiraGTx has a unique business model based on an innovative platform technology that enables the company to develop gene therapies for various diseases. The company works with a variety of technologies, including AAV vectors, DNA targeted integration, gene editing platform, and more. By combining these technologies, MeiraGTx can develop gene therapies tailored to the individual's condition. Segments: MeiraGTx consists of various divisions and products that focus on the development of therapeutics for various genetic diseases. Ophthalmology: MeiraGTx develops gene therapies for retinal diseases such as retinitis pigmentosa and macular degeneration. These therapies have the potential to preserve or even improve vision. Neurology: MeiraGTx develops therapeutics for neurological diseases such as Parkinson's and Huntington's. These gene therapies have the potential to alleviate the symptoms of the disease and improve the patient's quality of life. Hemophilia: MeiraGTx has developed gene therapies for hemophilia A and B based on its gene editing platform technology. These therapies have the potential to significantly improve the lives of hemophilia patients. Other products and therapies: MeiraGTx is also working on the development of gene therapies for cancer, cystic fibrosis, cardiovascular diseases, and autoimmune diseases. Summary: MeiraGTx is a leading company in the field of gene therapy and is committed to developing innovative therapeutics for various genetic diseases. With the help of technologies such as AAV vectors, DNA targeted integration, gene editing platform, and more, the company has the potential to change the lives of millions of patients. MeiraGTx is on track to revolutionize the healthcare industry, and it will be exciting to see what future advances the company will achieve. MeiraGTx Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding MeiraGTx Holdings's Sales Figures

The sales figures of MeiraGTx Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing MeiraGTx Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize MeiraGTx Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in MeiraGTx Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about MeiraGTx Holdings stock

How much revenue did MeiraGTx Holdings generate this year?

MeiraGTx Holdings has achieved a revenue of 32.78 M USD this year.

How much was the turnover of the company MeiraGTx Holdings compared to the previous year?

The revenue of MeiraGTx Holdings has increased by 133.83% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of MeiraGTx Holdings?

The revenue of MeiraGTx Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of MeiraGTx Holdings measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of MeiraGTx Holdings so important for investors?

The revenue of MeiraGTx Holdings is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does MeiraGTx Holdings pay?

Over the past 12 months, MeiraGTx Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MeiraGTx Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of MeiraGTx Holdings?

The current dividend yield of MeiraGTx Holdings is .

When does MeiraGTx Holdings pay dividends?

MeiraGTx Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MeiraGTx Holdings?

MeiraGTx Holdings paid dividends every year for the past 0 years.

What is the dividend of MeiraGTx Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is MeiraGTx Holdings located?

MeiraGTx Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von MeiraGTx Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MeiraGTx Holdings from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did MeiraGTx Holdings pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of MeiraGTx Holdings in the year 2023?

In the year 2023, MeiraGTx Holdings distributed 0 USD as dividends.

In which currency does MeiraGTx Holdings pay out the dividend?

The dividends of MeiraGTx Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MeiraGTx Holdings

Our stock analysis for MeiraGTx Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MeiraGTx Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.